–
CG Oncology, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
−0.61
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.6
FY22:
−35.2
FY23:
−55.4
FY24:
−115
FY25:
−191
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.4
FY22:
−35.2
FY23:
−55.4
FY24:
−115
FY25:
−189
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.8
FY22:
−35.4
FY23:
−48.6
FY24:
−88.0
FY25:
−161
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.8
FY22:
−35.4
FY23:
−48.6
FY24:
−88.0
FY25:
−161
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.